Stay updated on ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial
Sign up to get notified when there's something new on the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page.

Latest updates to the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision label updates from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden response rather than the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedThe study record page continues to display a 403 Forbidden error instead of study information.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe ClinicalTrials.gov page no longer displays the study record and instead shows a 403 Forbidden message.SummaryDifference16%

- Check29 days agoChange DetectedThe record presents a completed Phase 1 study of patisiran in Japanese healthy volunteers, with details on participation criteria, study arms, safety and pharmacokinetic outcomes, and record history.SummaryDifference38%

- Check43 days agoChange DetectedThe study page content was replaced by a 403 Forbidden page, showing a standard header with a Home link and site footer, indicating the record is currently inaccessible.SummaryDifference16%

Stay in the know with updates to ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page.